XML 68 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Pay vs Performance Disclosure      
Net loss attributable to Arrowhead Pharmaceuticals, Inc. $ (205,275) $ (176,063) $ (140,848)